BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 156026)

  • 1. Long term chrysotherapy: incidence of toxicity and efficacy during sequential time periods.
    Kean WF; Anastassiades TP
    Arthritis Rheum; 1979 May; 22(5):495-501. PubMed ID: 156026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proceedings: Eosinophilia during gold therapy.
    Jessop JD; Dippy J; Turnbull A; Bright M
    Rheumatol Rehabil; 1974 May; 13(2):75-80. PubMed ID: 4276506
    [No Abstract]   [Full Text] [Related]  

  • 3. Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis.
    Kean WF; Lock CJ; Howard-Lock HE; Buchanan WW
    Arthritis Rheum; 1982 Aug; 25(8):917-22. PubMed ID: 6214261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term chrysotherapy in rheumatoid arthritis.
    Srinivasan R; Miller BL; Paulus HE
    Arthritis Rheum; 1979 Feb; 22(2):105-10. PubMed ID: 105739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forty-seven years experience with gold therapy in 1,019 rheumatoid arthritis patients.
    Lockie LM; Smith DM
    Semin Arthritis Rheum; 1985 May; 14(4):238-46. PubMed ID: 2934818
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of rheumatoid arthritis with gold salts].
    Aranguena L; Hinojosa W; Chincaro C; Portugal J; Barrenechea O
    Rev Clin Esp; 1984 Jun 15-30; 173(5-6):305-8. PubMed ID: 6238373
    [No Abstract]   [Full Text] [Related]  

  • 7. Mucocutaneous side effects and continuation of aurotherapy in patients with rheumatoid arthritis.
    Taukumova LA; Mouravjoy YuV ; Gribakin SG
    Adv Exp Med Biol; 1999; 455():367-73. PubMed ID: 10599371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin rashes and stomatitis due to parenteral treatment of rheumatoid arthritis with sodium aurothiomalate.
    Svensson A; Theander J
    Ann Rheum Dis; 1992 Mar; 51(3):326-9. PubMed ID: 1533505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions.
    Klinefelter
    J Rheumatol; 1975 Mar; 2(1):21-7. PubMed ID: 127042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance chrysotherapy in rheumatoid arthritis: a comparison of 2 dose schedules.
    Griffin AJ; Gibson T; Huston G; Taylor A
    Ann Rheum Dis; 1981 Jun; 40(3):250-3. PubMed ID: 6787995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chrysotherapy and side effects (author's transl)].
    Eberl R
    Wien Klin Wochenschr Suppl; 1974; 25():3-22. PubMed ID: 4279096
    [No Abstract]   [Full Text] [Related]  

  • 12. Corneal chrysiasis and clinical improvement with chrysotherapy in rheumatoid arthritis.
    Prouse PJ; Kanski JJ; Gumpel JM
    Ann Rheum Dis; 1981 Dec; 40(6):564-6. PubMed ID: 6800311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate.
    Rodriguez-Pérez M; González-Dominguez J; Matarán L; Garcia-Pérez S; Salvatierra D
    J Rheumatol; 1994 Jan; 21(1):41-3. PubMed ID: 8151585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold therapy in rheumatoid arthritis.
    Schorn D; Anderson IF
    S Afr Med J; 1975 Aug; 49(37):1505-6. PubMed ID: 125934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chrysotherapy in psoriatic arthritis. Efficacy and toxicity compared to rheumatoid arthritis.
    Dorwart BB; Gall EP; Schumacher HR; Krauser RE
    Arthritis Rheum; 1978 Jun; 21(5):513-5. PubMed ID: 96841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelotoxicity of gold.
    Kay AG
    Br Med J; 1976 May; 1(6020):1266-8. PubMed ID: 817772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic toxicity associated with gold therapy.
    Favreau M; Tannenbaum H; Lough J
    Ann Intern Med; 1977 Dec; 87(6):717-9. PubMed ID: 412451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Continuous chrysotherapy of rheumatoid disease (evaluation of a retrospective study of 42 cases)].
    D'eshougues JR; Delcambre B; Maquerlot M; Defrance D
    Lille Med; 1977; 22(7):430-8. PubMed ID: 412025
    [No Abstract]   [Full Text] [Related]  

  • 19. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin.
    Tumiati B; Veneziani M; Bellelli A; Portioli I
    J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis.
    Lorber A; Atkins CJ; Chang CC; Lee YB; Starrs J; Bovy RA
    Ann Rheum Dis; 1973 Mar; 32(2):133-9. PubMed ID: 4632661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.